Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 868844

Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors


Rahelić, Dario; Javor, Eugen; Lucijanić, Tomo; Skelin, Marko
Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors // Annals of medicine, 49 (2017), 1; 51-62 doi:10.1080/07853890.2016.1226514 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 868844 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors

Autori
Rahelić, Dario ; Javor, Eugen ; Lucijanić, Tomo ; Skelin, Marko

Izvornik
Annals of medicine (0785-3890) 49 (2017), 1; 51-62

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Type 2 diabetes mellitus, macrovascular complications, mortality, antidiabetic drugs, sodium–glucose co-transporter 2 inhibitors

Sažetak
Elevated hemoglobin A1c (HbA1c) values correlate with microvascular and macrovascular complications. Thus, patients with type 2 diabetes mellitus (T2DM) are at an increased risk of developing macrovascular events. Treatment of T2DM should be based on a multifactorial approach because of its evidence regarding reduction of macrovascular complications and mortality in T2DM. It is well known that intensive glucose control reduces the risk of microvascular complications in T2DM, but the effects of antidiabetic drugs on macrovascular complications and mortality in T2DM are less clear. The results of recent trials have demonstrated clear evidence that empagliflozin and liraglutide reduce cardiovascular (CV) and all-cause mortality in T2DM, an effect that is absent in other members of antidiabetic drugs. Empagliflozin is a member of a novel class of antidiabetic drugs, the sodium–glucose co-transporter 2 (SGLT2) inhibitors. Two ongoing randomized clinical trials involving other SGLT2 inhibitors, canagliflozin and dapagliflozin, will provide additional evidence of the beneficial effects of SGLT2 inhibitors in T2DM population. The aim of this paper is to systematically present the latest evidence regarding the usage of antidiabetic drugs, and the reduction of macrovascular complications and mortality. A special emphasis is put on the novel class of antidiabetic drugs, of SGLT2 inhibitors.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
KBC "Sestre Milosrdnice",
Opća bolnica Šibenik,
Klinička bolnica "Dubrava"

Profili:

Avatar Url Dario Rahelić (autor)

Avatar Url Marko Skelin (autor)

Avatar Url Tomo Lucijanić (autor)

Citiraj ovu publikaciju

Rahelić, Dario; Javor, Eugen; Lucijanić, Tomo; Skelin, Marko
Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors // Annals of medicine, 49 (2017), 1; 51-62 doi:10.1080/07853890.2016.1226514 (međunarodna recenzija, pregledni rad, znanstveni)
Rahelić, D., Javor, E., Lucijanić, T. & Skelin, M. (2017) Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors. Annals of medicine, 49 (1), 51-62 doi:10.1080/07853890.2016.1226514.
@article{article, year = {2017}, pages = {51-62}, DOI = {10.1080/07853890.2016.1226514}, keywords = {Type 2 diabetes mellitus, macrovascular complications, mortality, antidiabetic drugs, sodium–glucose co-transporter 2 inhibitors}, journal = {Annals of medicine}, doi = {10.1080/07853890.2016.1226514}, volume = {49}, number = {1}, issn = {0785-3890}, title = {Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors}, keyword = {Type 2 diabetes mellitus, macrovascular complications, mortality, antidiabetic drugs, sodium–glucose co-transporter 2 inhibitors} }
@article{article, year = {2017}, pages = {51-62}, DOI = {10.1080/07853890.2016.1226514}, keywords = {Type 2 diabetes mellitus, macrovascular complications, mortality, antidiabetic drugs, sodium–glucose co-transporter 2 inhibitors}, journal = {Annals of medicine}, doi = {10.1080/07853890.2016.1226514}, volume = {49}, number = {1}, issn = {0785-3890}, title = {Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus : a new perspective on sodium–glucose co-transporter 2 inhibitors}, keyword = {Type 2 diabetes mellitus, macrovascular complications, mortality, antidiabetic drugs, sodium–glucose co-transporter 2 inhibitors} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font